Adjunctive interleukin-2 for the treatment of drug-susceptible tuberculosis: a randomized control trial in China.
Nie W, Wang J, Zeng J, Wang Q, Du Y, Tan Q, Xie W, Deng Q, Deng G, Li X, Li Z, Zhao J, Pang J, Luan K, Chu L, Duan H, Zhang C, Ji Q, Chen X, Chen J, Wang N, Chen Y, Qiu C, Deng A, Ren P, Liu Y, Li C, Cao S, Liu H, Yan H, Chu N.
Nie W, et al. Among authors: chen j, chen x, chen y.
Infection. 2022 Apr;50(2):413-421. doi: 10.1007/s15010-021-01698-3. Epub 2021 Sep 25.
Infection. 2022.
PMID: 34562262
Clinical Trial.